{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:59:55Z","timestamp":1790711995854,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijbiomac.2022.09.101","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T02:35:41Z","timestamp":1663295741000},"page":"1605-1618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Preparation, physicochemical, and retinal anti-angiogenic evaluation of poloxamer hydrogel containing dexamethasone\/avastin-loaded chitosan-N-acetyl-L-cysteine nanoparticles"],"prefix":"10.1016","volume":"220","author":[{"given":"Sayed Latif","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajihe","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeshir","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Abolfazl","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"Lai","year":"2013","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0010","series-title":"Meta-Analysis of the Sensitivity of Decision Support Systems in Diagnosing Diabetic Retinopathy, MEDINFO 2019: Health and Wellbeing e-Networks for All","first-page":"878","author":"Sim\u00f5es","year":"2019"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.09.101_bb0015","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","article-title":"Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies","volume":"26","author":"Ciulla","year":"2003","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.09.101_bb0020","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2146\/ajhp080455","article-title":"Understanding and managing the possible adverse effects associated with bevacizumab","volume":"66","author":"Shord","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.09.101_bb0025","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.101_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1444-0938.2008.00305.x","article-title":"Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice","volume":"91","author":"Van Wijngaarden","year":"2008","journal-title":"Clin. Exp. Optom."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.09.101_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-409X(93)90025-Y","article-title":"Preparation, structure and diffusional behavior of hydrogels in controlled release","volume":"11","author":"Peppas","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.09.101_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin\u00ae to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0939-6411(03)00147-4","article-title":"Thiolated chitosans","volume":"57","author":"Bernkop-Schn\u00fcrch","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5A","key":"10.1016\/j.ijbiomac.2022.09.101_bb0050","first-page":"3183","article-title":"Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin","volume":"20","author":"Aluigi","year":"2000","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.101_bb0055","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1007\/s11033-011-1148-9","article-title":"Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats","volume":"39","author":"Zhu","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(97)00083-5","article-title":"Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers","volume":"153","author":"Calvo","year":"1997","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0065","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S0039-6257(02)00387-9","article-title":"Diabetic retinopathy: more than meets the eye","volume":"47","author":"Gardner","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0070","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.8b07865","article-title":"Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumor microenvironment","author":"Martin","year":"2019","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.101_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejpb.2010.12.018","article-title":"Association of ranibizumab (Lucentis\u00ae) or bevacizumab (Avastin\u00ae) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment","volume":"78","author":"Veurink","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.101_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-409X(01)00203-4","article-title":"Environment-sensitive hydrogels for drug delivery","volume":"53","author":"Qiu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.101_bb0085","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/ma3031746","article-title":"Injectable, biodegradable hydrogels for tissue engineering applications","volume":"3","author":"Tan","year":"2010","journal-title":"Materials"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.09.101_bb0090","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3109\/03639041003680826","article-title":"PLGA\u2013PEG\u2013PLGA hydrogel for ocular drug delivery of dexamethasone acetate","volume":"36","author":"Gao","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0095","series-title":"Thermosensitive Sol-Gel Reversible Hydrogels","first-page":"37","volume":"54","author":"Jeong","year":"2002"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.09.101_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2007.09.005","article-title":"Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system","volume":"350","author":"Ma","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.101_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0885328211406563","article-title":"Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation","volume":"27","author":"Chen","year":"2012","journal-title":"J. Biomater. Appl."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.101_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejpb.2011.11.013","article-title":"Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery","volume":"80","author":"Casolaro","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.101_bb0115","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/10717544.2018.1458922","article-title":"Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia","volume":"25","author":"Akhlaq","year":"2018","journal-title":"Drug Delivery"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.09.101_bb0125","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/pr8111350","article-title":"Hydroxypropyl methylcellulose-based hydrogel copolymeric for controlled delivery of galantamine hydrobromide in dementia","volume":"8","author":"Bashir","year":"2020","journal-title":"Processes"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.09.101_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2007.06.040","article-title":"Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate","volume":"347","author":"Schmitz","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.101_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/1735-5362.228918","article-title":"Preparation and characterization of an injectable thermosensitive hydrogel for simultaneous delivery of paclitaxel and doxorubicin","volume":"13","author":"Rezazadeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijbiomac.2013.05.034","article-title":"Sustained release of Avastin\u00ae from polysaccharides cross-linked hydrogels for ocular drug delivery","volume":"60","author":"Xu","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.09.101_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00232-010-9291-0","article-title":"CD spectroscopy of peptides and proteins bound to large unilamellar vesicles","volume":"236","author":"Ladokhin","year":"2010","journal-title":"J. Membr. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.09.101_bb0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.101_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10295-014-1437-0","article-title":"Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli","volume":"41","author":"Akbari","year":"2014","journal-title":"Journal of Industrial Microbiology and Biotechnology"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0160","first-page":"556","article-title":"Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor","volume":"14","author":"Kim","year":"2008","journal-title":"Mol. Vis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.09.101_bb0165","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/acs.molpharmaceut.6b00335","article-title":"PLGA microparticles entrapping chitosan-based nanoparticles for the ocular delivery of ranibizumab","volume":"13","author":"Elsaid","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.101_bb0170","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1167\/iovs.11-9341","article-title":"In vitro biocompatibility of various polymer-based microelectrode arrays for retinal prosthesis","volume":"53","author":"Bae","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.09.101_bb0175","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1248\/bpb.31.1541","article-title":"Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.09.101_bb0180","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00125-007-0734-9","article-title":"Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes","volume":"50","author":"Zheng","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.101_bb0185","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1167\/iovs.02-0807","article-title":"VEGF164 is proinflammatory in the diabetic retina","volume":"44","author":"Ishida","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbm.b.31161","article-title":"Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin","volume":"88","author":"Wang","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0195","series-title":"Conjugation of 3\u2032-Azido-3\u2032-Deoxythymidine With Heparin, Doklady Chemistry, SP MAIK Nauka\/Interperiodica","first-page":"95","author":"Ponedel\u2019kina","year":"2008"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.09.101_bb0200","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/bm0502258","article-title":"Preparation and characterization of chitosan-based nanoparticles","volume":"6","author":"Bodnar","year":"2005","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.101_bb0210","article-title":"Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ab.2018.06.003","article-title":"Secondary structure assessment of formulated bevacizumab in the presence of SDS by deep ultraviolet resonance raman (DUVRR) spectroscopy","volume":"555","author":"Qiu","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119895","article-title":"Formulation of nanoliposome-encapsulated bevacizumab (Avastin): statistical optimization for enhanced drug encapsulation and properties evaluation","volume":"590","author":"Malakouti-Nejad","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2007.09.001","article-title":"Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system","volume":"33","author":"Hombach","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.09.101_bb0230","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.10149","article-title":"Formulation pH modulates the interaction of insulin with chitosan nanoparticles","volume":"91","author":"Ma","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2022.09.101_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2005.06.001","article-title":"Modulation of surface charge, particle size and morphological properties of chitosan\u2013TPP nanoparticles intended for gene delivery","volume":"44","author":"Gan","year":"2005","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0240","first-page":"166","article-title":"Preparation of chitosan\u2013TPP nanoparticles and their physical and biological properties, asian","volume":"11","author":"Lee","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2022.09.101_bb0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-3659(97)00252-6","article-title":"DNA-polycation nanospheres as non-viral gene delivery vehicles","volume":"53","author":"Leong","year":"1998","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.colsurfb.2010.07.006","article-title":"Kinetics of coacervation transition versus nanoparticle formation in chitosan\u2013sodium tripolyphosphate solutions","volume":"81","author":"Kaloti","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.09.101_bb0255","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/pc.22415","article-title":"Chitosan nanoparticles as therapeutic protein nanocarriers: the effect of ph on particle formation and encapsulation efficiency","volume":"34","author":"Mattu","year":"2013","journal-title":"Polym. Compos."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.09.101_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-014-2355-9","article-title":"Enhanced paracellular and transcellular paclitaxel permeation by chitosan\u2013vitamin E succinate\u2013N-acetyl-l-cysteine copolymer on Caco-2 cell monolayer","volume":"16","author":"Lian","year":"2014","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijbiomac.2022.09.101_bb0280","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2147\/IJN.S316564","article-title":"Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy","volume":"16","author":"Radwan","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.09.101_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3129\/i09-243","article-title":"Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab)","volume":"45","author":"Ehmann","year":"2010","journal-title":"Can. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.09.101_bb0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-016-0869-6","article-title":"Nap interferes with hypoxia-inducible factors and VEGF expression in retina of diabetic rats","volume":"61","author":"D\u2019Amico","year":"2017","journal-title":"J. Mol. Neurosci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022020323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022020323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:58:11Z","timestamp":1758880691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022020323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":54,"alternative-id":["S0141813022020323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.101","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation, physicochemical, and retinal anti-angiogenic evaluation of poloxamer hydrogel containing dexamethasone\/avastin-loaded chitosan-N-acetyl-L-cysteine nanoparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}